HUNTER OKESON: Open Payments
NPI 1871065979 · MARICOPA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $350 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $270 |
| ABBVIE INC. | 9 | $195 |
| Astellas Pharma US Inc | 5 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
| Kestra Medical Technology Services, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Abbott Laboratories | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, Veozah, QULIPTA, CAPLYTA, MAVYRET, Kerendia, UBRELVY.
Industry payments across AZ — which companies pay providers there.
